Invention Grant
- Patent Title: Melt-extruded release controlled pharmaceutical composition and oral dosage form comprising the same
-
Application No.: US14758258Application Date: 2013-12-20
-
Publication No.: US10143659B2Publication Date: 2018-12-04
- Inventor: Sang-Yeob Park , Hye-Jung Lim , Kyung-Hee Kim
- Applicant: Samyang Biopharmaceuticals Corporation
- Applicant Address: KR Seoul
- Assignee: Samyang Biopharmaceutical Corporation
- Current Assignee: Samyang Biopharmaceutical Corporation
- Current Assignee Address: KR Seoul
- Agency: Marshall, Gerstein & Borun LLP
- Priority: KR10-2012-0158570 20121231
- International Application: PCT/KR2013/011972 WO 20131220
- International Announcement: WO2014/104670 WO 20140703
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K31/519 ; A61K47/32 ; A61K31/517 ; A61K9/16
Abstract:
Disclosed are a controlled release pharmaceutical composition, comprising a melt-extruded pellet including a water-insoluble ammonium methacrylate copolymer, a polyvinyl acetate, and an active ingredient; and a polymer coating layer including a water-insoluble ammonium methacrylate copolymer formed on the surface of the pellet, and an oral formulation including the pharmaceutical composition.
Public/Granted literature
- US20160213621A1 Melt-Extruded Release Controlled Pharmaceutical Composition and Oral Dosage Form Comprising the Same Public/Granted day:2016-07-28
Information query
